4.6 Review

An Insight into All Tested Small Molecules against Fusarium oxysporum f. sp. Albedinis: A Comparative Review

Journal

MOLECULES
Volume 27, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/molecules27092698

Keywords

pyrazole; imidazole; B-keto-enol; amino acid; quinoxaline; Bayoud; Fusarium oxysporum f; sp; albedinis

Funding

  1. ANPMA/CNRST/UMP 2020-2023 Project: Formulations fongiques, insecticide ou acaricides d'huiles essentielles des plantes aromatiques et medicinales et de leurs extraits aqueux
  2. Taif University, Taif, Saudi Arabia [TURSP2020/91]
  3. ANPMA/CNRST/UMP 2020-2023 Project
  4. Taif University Researchers Supporting Project, Taif, Saudi Arabia [TURSP2020/91]

Ask authors/readers for more resources

In this review, the authors examined 100 compounds tested for their effectiveness against Bayoud disease, and identified 12 most efficient compounds. These compounds have common antifungal pharmacophore sites, while others have pharmacophore sites influenced by substituents on phenyl rings. This research provides valuable insights into combating the pathogen causing Bayoud disease.
Bayoud disease affects date palms in North Africa and the Middle East, and many researchers have used various methods to fight it. One of those methods is the chemical use of synthetic compounds, which raises questions centred around the compounds and common features used to prepare targeted molecules. In this review, 100 compounds of tested small molecules, collected from 2002 to 2022 in Web of Sciences, were divided into ten different classes against the main cause of Bayoud disease pathogen Fusarium oxysporum f. sp. albedinis (F.o.a.) with structure-activity relationship (SAR) interpretations for pharmacophore site predictions as (delta(-)center dot center dot center dot delta(-)), where 12 compounds are the most efficient (one compound from each group). The compounds, i.e., (Z)-1-(1.5-Dimethyl-1H-pyrazole-3-yl)-3-hydroxy but-2-en-1-one 7, (Z)-3-(phenyl)-1-(1,5-dimethyl-1H-pyrazole-3-yl)-3-hydroxyprop-2-en-1-one 23, (Z)-1-(1,5-Dimethyl-1H-pyrazole-3-yl)-3-hydroxy-3-(pyridine-2-yl)prop-2-en-1-one 29, and 2,3-bis-[(2-hydroxy-2-phenyl)ethenyl]-6-nitro-quinoxaline 61, have antifungal pharmacophore sites (delta(-)center dot center dot center dot delta(-)) in common in N1---O4, whereas other compounds have only one delta(-) pharmacophore site pushed by the donor effect of the substituents on the phenyl rings. This specificity interferes in the biological activity against F.o.a. Further understanding of mechanistic drug-target interactions on this subject is currently underway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available